The Center for Genetics and Society blog highlights the latest developments in the social, political, and ethical implications of human biotechnologies, with contributions from staff, fellows, consultants, and guest authors.
Biopolitical Times
This month’s gene therapy news includes celebrations of promising new developments running beside gloomy takes on the future of the industry.
Early in February, a STAT headline quipped “The CRISPR companies are not OK”:
Interviews with over 75...
President Trump scored a bunch of generally favorable mainstream headlines recently by announcing that he was ordering expanded access to in vitro fertilization (IVF). He had announced in October that he was “the father of IVF” although he also...